SCHEMBL607772

SCHEMBL607772

CC(C)C[CH]NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSMB5 P28074 15/20 0.66
LONP1 P36776 13/20 0.66
PSMB8 P28062 10/20 0.66
PSMB9 P28065 10/20 0.66
PSMB6 P28072 10/20 0.66
PSMB10 P40306 10/20 0.66
PSMB11 A5LHX3 9/20 0.66
PSMA7 O14818 9/20 0.66
PSMB1 P20618 9/20 0.66
PSMA1 P25786 9/20 0.66
PSMA2 P25787 9/20 0.66
PSMA3 P25788 9/20 0.66
PSMA4 P25789 9/20 0.66
PSMA5 P28066 9/20 0.66
PSMB4 P28070 9/20 0.66
PSMB3 P49720 9/20 0.66
PSMB2 P49721 9/20 0.66
PSMA6 P60900 9/20 0.66
PSMA8 Q8TAA3 9/20 0.66
PSMB7 Q99436 9/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20093498 0.85 CTSL (0.78) PSMB5LONP1PSMB8PSMB9PSMB6
SCHEMBL18848799 0.83 PSMB5 (0.78) PSMB5LONP1PSMB8PSMB9PSMB6
SCHEMBL16492912 0.83 PSMB5 (0.78) PSMB5LONP1PSMB8PSMB9PSMB6
SCHEMBL464470 0.83 PSMB5 (0.78) PSMB5LONP1PSMB8PSMB9PSMB6
SCHEMBL16362648 0.83 PSMB5 (0.78) PSMB5LONP1PSMB8PSMB9PSMB6
SCHEMBL21558117 0.83 PSMB5 (0.78) PSMB5LONP1PSMB8PSMB9PSMB6
SCHEMBL24390721 0.82 PSMB5 (0.80) PSMB5LONP1PSMB8PSMB9PSMB6
SCHEMBL3656124 0.82 CTSL (0.74) PSMB5LONP1PSMB8PSMB9PSMB6
SCHEMBL16189897 0.82 PSMB5 (0.80) PSMB5LONP1PSMB8PSMB9PSMB6
SCHEMBL1913443 0.82 PSMB5 (0.76) PSMB5LONP1PSMB8PSMB9PSMB6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 106 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110314222-A Application of the composition of bortezomib and pabishta or Vorinostat in the drug of preparation treatment drug-resistant type MLL leukaemia 上海交通大学医学院附属瑞金医院 2019-10-11 CN disclosed
CN-110312727-A A kind of improved method for preparing borate 费森尤斯卡比肿瘤学有限公司 2019-10-08 CN disclosed
CN-110172051-A IRE-1 alpha inhibitor 复星弘创(苏州)医药科技有限公司 2019-08-27 CN disclosed
CN-107082770-B IRE-1 alpha inhibitor 复星弘创(苏州)医药科技有限公司 2019-04-23 CN disclosed
WO-2018150386-A1 AN IMPROVED PROCESS FOR THE PREPARATION OF BORONIC ACID ESTERS FRESENIUS KABI ONCOLOGY LTD. (IN) 2018-08-23 WO disclosed
US-9353218-B2 Kit for multifunctional compounds forming crosslinked biomaterials ANGIOTECH PHARMACEUTICALS, INC. 2016-05-31 US disclosed
US-9326934-B2 Drug delivery from rapid gelling polymer composition ANGIOTECH INTERNATIONAL AG 2016-05-03 US disclosed
EP-2181704-B1 Drug delivery from rapid gelling polymer composition ANGIOTECH INT AG (CH) 2015-05-06 EP disclosed
US-20130289235-A1 MULTIFUNCTIONAL COMPOUNDS FOR FORMING CROSSLINKED BIOMATERIALS AND METHODS OF PREPARATION AND USE ANGIOTECH PHARMACEUTICALS, INC. (CA) 2013-10-31 US disclosed
US-8486437-B2 Multifunctional compounds for forming crosslinked biomaterials and methods of preparation and use ANGIOTECH PHARMACEUTICALS (US), INC. (US) 2013-07-16 US disclosed
WO-2005051452-A2 POLYMER COMPOSITIONS AND METHODS FOR THEIR USE ANGIOTECH INTERNATIONAL AG (CH) 2005-06-09 WO disclosed
WO-2005051316-A2 POLYMER COMPOSITIONS AND METHODS FOR THEIR USE ANGIOTECH INTERNATIONAL AG (CH) 2005-06-09 WO disclosed
WO-2005051444-A2 SOFT TISSUE IMPLANTS AND ANTI-SCARRING AGENTS ANGIOTECH INTERNATIONAL AG (CH) 2005-06-09 WO disclosed
WO-2005051483-A2 ELECTRICAL DEVICES AND ANTI-SCARRING AGENTS ANGIOTECH INTERNATIONAL AG (CH) 2005-06-09 WO disclosed
WO-2005051871-A2 IMPLANTABLE SENSORS AND IMPLANTABLE PUMPS AND ANTI-SCARRING AGENTS ANGIOTECH INTERNATIONAL AG (CH) 2005-06-09 WO disclosed
WO-2005046516-A2 MEDICAL IMPLANTS AND ANTI-SCARRING AGENTS ANGIOTECH INTERNATIONAL AG (CH) 2005-05-26 WO disclosed
WO-2005018683-A2 ANASTOMOTIC CONNECTOR DEVICES ANGIOTECH INTERNATIONAL AG (CH) 2005-03-03 WO disclosed
US-20040260318-A1 Anastomotic connector devices ANGIOTECH INTERNATIONAL AG (CH) 2004-12-23 US disclosed
US-20040225077-A1 Drug delivery from rapid gelling polymer composition ANGIOTECH INTERNATIONAL AG (CH) 2004-11-11 US disclosed
WO-2004060346-A2 DRUG DELIVERY FROM RAPID GELLING POLYMER COMPOSITION ANGIOTECH INTERNATIONAL AG (CH) 2004-07-22 WO disclosed